OFFICIAL STOCK MARKET AND ECONOMY THREAD VOL. A NEW CHAPTER

SunRun has made me a killing

Finally exited Wells, jesus what a terrible buy, needless to say I have not made a killing
 
Last edited:
flacobey said:
Not surprised to see that SQ had a great quarter, especially after PayPal’s results. Every growth portfolio should have some exposure to SQ, PYPL, MA or V. The US non-cash payments market will be dominated by these names over the next 10-years. You really can’t understate the network effect when it comes platforms like Cash app.
Click to expand...
SQ is headed for $200 before 2021

My average is @ 43$ and I refuse to purchase more, I should though lol
 
IMG_20200804_184004_669.jpg


Facts.
 
Got in on the SPY dip at the final hours of the trading day
I like it here (only trading SPY)
Even though I had to wait until the final hours
I do better with this etf than other tickers
The AMD story is a amazing one I remember when it was under $20 two years ago
I should have been buying that **** up when I was putting $100 weekly in Robin Hood :lol::lol:
 
LVGO TDOC just merged. Wow.

debating on keeping square. Apparently all their revenue growth came from bitcoin which is a 2% margin business. Torn here because if btc is growing rapidly enough to keep them afloat during the pandemic that should bode well for when business returns.
 
johnnyredstorm said:
LVGO TDOC just merged. Wow.

debating on keeping square. Apparently all their revenue growth came from bitcoin which is a 2% margin business. Torn here because if btc is growing rapidly enough to keep them afloat during the pandemic that should bode well for when business returns.
Click to expand...

I've wanted teladoc for a long time just never pulled the trigger cause it went up so fast and had already bought into LVGO, so I guess this works out great haha

What do you think bout the news? This good? Bad? Do you sell the shares now and cash out or wait for the conversion? And how does that work anyway haha never had a company I had shares in merge before..
 
JPMorgan upgrades Novavax on potential 'best-in-class' COVID vaccine
JPMorgan analyst Eric Joseph upgraded Novavax to Overweight from Neutral with a price target of $275, up from $105. The stock in premarket trading is up 17%, or $26.83, to $184.00. The analyst is "pleasantly impressed" by last night's initial immunogenicity/safety profile for NVX-CoV2373 in the Phase 1 COVID-19 vaccine results. It is "not too far a stretch" to conclude the activity of NVX-CoV2373 "looks best-in-class," particularly when anchored to one of the more "stringent" human convalescent sera cohorts reported to date, Joseph tells investors in a research note. On safety, the analyst views the tolerability profile of both doses "as comfortably within the bounds of licensure-eligible candidate." He believes "relative valuations" favor Novavax over the near-term ahead of the first of the competitor Phase 3 COVID-19 vaccine efficacy readouts.
 
shibadekobe said:
JPMorgan upgrades Novavax on potential 'best-in-class' COVID vaccine
JPMorgan analyst Eric Joseph upgraded Novavax to Overweight from Neutral with a price target of $275, up from $105. The stock in premarket trading is up 17%, or $26.83, to $184.00. The analyst is "pleasantly impressed" by last night's initial immunogenicity/safety profile for NVX-CoV2373 in the Phase 1 COVID-19 vaccine results. It is "not too far a stretch" to conclude the activity of NVX-CoV2373 "looks best-in-class," particularly when anchored to one of the more "stringent" human convalescent sera cohorts reported to date, Joseph tells investors in a research note. On safety, the analyst views the tolerability profile of both doses "as comfortably within the bounds of licensure-eligible candidate." He believes "relative valuations" favor Novavax over the near-term ahead of the first of the competitor Phase 3 COVID-19 vaccine efficacy readouts.
Click to expand...

I was just in the process of tagging you to see if you seen this haha... And premarket is coooookin' :nthat: :nthat:
 
ShoeGod1423 said:
I've wanted teladoc for a long time just never pulled the trigger cause it went up so fast and had already bought into LVGO, so I guess this works out great haha

What do you think bout the news? This good? Bad? Do you sell the shares now and cash out or wait for the conversion? And how does that work anyway haha never had a company I had shares in merge before..
Click to expand...
fair value I think is 159 a share, if lvgo goes above that I’ll sell because that’s beating the conversion rate. I’ve never had a merger before either so idk :lol: this sucks a little because lvgo is a $300 stock on its own but if you like TDOC this is a win big
shibadekobe said:
JPMorgan upgrades Novavax on potential 'best-in-class' COVID vaccine
JPMorgan analyst Eric Joseph upgraded Novavax to Overweight from Neutral with a price target of $275, up from $105. The stock in premarket trading is up 17%, or $26.83, to $184.00. The analyst is "pleasantly impressed" by last night's initial immunogenicity/safety profile for NVX-CoV2373 in the Phase 1 COVID-19 vaccine results. It is "not too far a stretch" to conclude the activity of NVX-CoV2373 "looks best-in-class," particularly when anchored to one of the more "stringent" human convalescent sera cohorts reported to date, Joseph tells investors in a research note. On safety, the analyst views the tolerability profile of both doses "as comfortably within the bounds of licensure-eligible candidate." He believes "relative valuations" favor Novavax over the near-term ahead of the first of the competitor Phase 3 COVID-19 vaccine efficacy readouts.
Click to expand...
Hospitalized eight people and that data was hidden. ****ing joke.
 
Pfizer, BioNTech in deal with Canada to supply COVID vaccine hopeful

Canada on Wednesday secured supplies of an experimental COVID-19 vaccine developed by Pfizer and German biotech firm BioNTech for delivery in 2021 if the compound wins regulatory approval.


Financial details of the agreement were not disclosed, Pfizer and BioNTech said in a joint statement, but added that the terms were based on the timing of delivery and the volume of doses.
Click to expand...
 
jrod54life said:
joined the crew and sold off all LVGO after the merger with TDOC to lock in the major gains
Click to expand...
Same here. Bought two shares of shop, holding a little cash and adding to my mutual funds a little. Amazing trade lvgo was. Damn shame it got bought out. Would’ve been 300 easy.
 
johnnyredstorm said:
Same here. Bought two shares of shop, holding a little cash and adding to my mutual funds a little. Amazing trade lvgo was. Damn shame it got bought out. Would’ve been 300 easy.
Click to expand...
the potential man well cant complain gains are gains. well time to have some cash in hand and see where to go next might get in on more PINS on any dip i see
 
jrod54life said:
the potential man well cant complain gains are gains. well time to have some cash in hand and see where to go next might get in on more PINS on any dip i see
Click to expand...
Got some money in that account that i plan on using to add to pins and fsly on any dips. Added a little crwd today.
 
You must log in or register to reply here.

Similar threads

tr1ll
I propose a new SPOILER rule for media in NT's Terms and Rules.
Replies
20
Views
755
TSCQ
TSCQ
Manny Fernandez718
Learning a new language thread
Replies
5
Views
903
dman14
dman14
frenchbreadbuilds
atmos Will To Close Its US Stores And Website To Focus On Japan/Asia Business
Replies
16
Views
2K
Beruseruku Desu
Beruseruku Desu

Thread Gallery

View Full Gallery

The ultimate sneaker enthusiast community.

NikeTalk was created as a way of giving back to both the sneaker enthusiast community and to the greater global community of which we are all a part.

NikeTalk is NOT affiliated with Nike Inc. in any way, shape, or form. All opinions expressed herein do not necessarily reflect those of Nike, Inc.

© 1999-2024 NikeTalk.com

Share this page

Back
Top Bottom